“After the CC I was in agreement that we should try and get all 75 in the M2M trial before releasing data, but I now think the sooner the better.”
I disagree and believe that CYDY should wait until full enrollment of the 75 patient trial.
(1)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-